WHAT TO EXPECT
Medication risk resolved — not just identified
Medilens provides an early clinical review pathway for medication decisions in workers compensation, helping align treatment plans between injured people, treating doctors, and insurers before issues escalate.
HOW MEDILENS CREATES RESOLUTION
An integrated care model that benefits everyone - patient, clinician and insurer
Medication-related risk identified
The claim has a medication issue that could increase harm, cost, delay, or dispute.
Pharmacist engages the prescriber
A peer-to-peer model that helps clinicians make safer prescribing decisions, reduce unnecessary medications, and apply changes confidently in practice.
.png){kind=small}
Medication risk resolved
Medication may be ceased, reduced, adjusted, or substituted, with the treating doctor’s agreement and a clearly documented, defensible basis.
Declining or restricting funding may reduce immediate cost pressure, but the clinical risk can remain with the claimant, another prescriber, or out-of-pocket access — creating dispute without resolving the prescribing pattern.
Shared decisions, shared outcomes.
Medilens works because it resolves the medication problem clinically. That creates a practical benefit for the person receiving care, the doctor prescribing treatment, and the insurer managing claim risk.
For the injured person
Safer medication use, fewer adverse effects such as sedation or cognitive impairment, and a clearer path back to recovery and function.
For the treating doctor
A collaborative medication plan from another clinical professional — not a funding decline from an insurer — while prescribing authority remains with the doctor.
For the insurer
Claim risk is reduced at the source, with a defensible pathway that supports recovery instead of creating an adversarial funding dispute.